Showing results (1-10 of 183) with videos related to
Sort By:
Pageof 19
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 4, 2011
[PARP inhibitors for cancer therapy]Hiroko Saito, Yoshio MikiBiochemical and Biophysical Research Communications|March 8, 2021
CDK1 inhibitor controls G2/M phase transition and reverses DNA damage sensitivityShigeaki Sunada, Hiroko Saito, Doudou Zhang, et al.Cell Cycle (Georgetown, Tex.)|July 20, 2016
BRCA2 mediates centrosome cohesion via an interaction with cytoplasmic dyneinSadiya Malik, Hiroko Saito, Miho Takaoka, et al.Cancer Research|January 23, 2014
BRCA2 phosphorylated by PLK1 moves to the midbody to regulate cytokinesis mediated by nonmuscle myosin IICMiho Takaoka, Hiroko Saito, Katsuya Takenaka, et al.Biochemical and Biophysical Research Communications|December 24, 2021
BRCA2 represses the transcriptional activity of pS2 by E2-ERαMio Fukuda, Yo Tojo, Ami Sato, et al.Genomics|May 31, 2002
Identification and characterization of the human protein kinase-like gene NTKL: mitosis-specific centrosomal localization of an alternatively spliced isoformMasahiro Kato, Ken-ichi Yano, Keiko Morotomi-Yano, et al.The Journal of Biological Chemistry|October 30, 2001
Human regulatory factor X 4 (RFX4) is a testis-specific dimeric DNA-binding protein that cooperates with other human RFX membersKeiko Morotomi-Yano, Ken-ichi Yano, Hiroko Saito, et al.Cancer Science|August 28, 2009
BRCA2 interacts with the cytoskeletal linker protein plectin to form a complex controlling centrosome localizationTakayoshi Niwa, Hiroko Saito, Shinobu Imajoh-ohmi, et al.Biochemical and Biophysical Research Communications|February 9, 2007
Interference with BRCA2, which localizes to the centrosome during S and early M phase, leads to abnormal nuclear divisionAkira Nakanishi, Xiangzi Han, Hiroko Saito, et al.Biochemical and Biophysical Research Communications|January 4, 2014
Centrosomal BRCA2 is a target protein of membrane type-1 matrix metalloproteinase (MT1-MMP)Nadila Wali, Kana Hosokawa, Sadiya Malik, et al.Pageof 19